Company Monitoring Page for GSK

latest headlines for company on cafepharma

GSK explores new avenues for JAK drug in $1.9B Sierra buy amid pending FDA decision
Fierce Biotech
Mon, 12/12/22 - 10:23 am
Tags:
GSK, Sierra Oncology, momelotinib, myelofibrosis, ASH 2022
GSK picks downtown London for new corporate headquarters
WRAL Techwire
Mon, 12/12/22 - 10:20 am
Tags:
GSK, London, UK, headquarters
GSK shares surge as US judge dismisses Zantac cancer claims
The Guardian, UK
Thu, 12/8/22 - 10:10 am
Tags:
GSK, legal, Zantac
GSK, Sanofi, Takeda sign with Singapore partnership to advance biologic manufacturing
Fierce Pharma
Tue, 12/6/22 - 08:54 pm
Tags:
GSK, Sanofi, Takeda, Singapore, biologics
GSK Notches Phase III Win for Jemperli in Endometrial Cancer
BioSpace
Sun, 12/4/22 - 01:13 pm
Tags:
GSK, Jemperli, clinical trials, endometrial cancer
GSK unveils Keytruda head-to-head data in lung cancer—and they look good at first glance
Fierce Pharma
Wed, 11/30/22 - 07:58 pm
Tags:
GSK, Merck, Jemperli, Keytruda, clinical trials, non-small cell lung cancer
GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care
Fierce Pharma
Tue, 11/29/22 - 08:29 pm
Tags:
GSK, lupus, Benlysta, patients, COVID-19, pharma marketing
When is big pharma no longer big pharma?
EP Vantage
Sat, 11/26/22 - 07:20 pm
Tags:
GSK, market cap, Big Pharma
GSK’s “crown jewels” already look tarnished
EP Vantage
Wed, 11/23/22 - 07:27 am
Tags:
GSK, Blenrep, Emma Walmsley, daprodustat, gepotidacin, otilimab, Jemperli, Zejula, cabotegravir
GSK to pull blood cancer drug from US market after study failure
BioPharma Dive
Tue, 11/22/22 - 11:08 am
Tags:
GSK, blood cancer, Blenrep, clinical trials, Multiple Myeloma
GSK to slash about 150 consumer commercial jobs in India
Fierce Pharma
Mon, 11/21/22 - 06:35 pm
Tags:
GSK, India, layoffs
GSK, J&J and AZ top global drug access index, but foundation says plenty more work needs to be done
Fierce Pharma
Thu, 11/17/22 - 12:13 pm
Tags:
GSK, JNJ, AstraZeneca, Access to Medicine Foundation, drug access
GSK's cell therapy retreat hits another partner as drugmaker exits Immatics collaboration
Endpoints
Thu, 11/17/22 - 10:38 am
Tags:
GSK, cell therapy, Immatics
GSK Digital & Tech Executive Takes Drug-Hunting Inspiration from Outer Space
MedCity News
Tue, 11/15/22 - 10:50 am
Tags:
GSK, artificial intelligence, drug discovery
GSK reports positive Phase IIa data for tuberculosis treatment
Clinical Trials Arena
Tue, 11/15/22 - 10:28 am
Tags:
GSK, clinical trials, GSK3036656, tuberculosis
AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions
Fierce Pharma
Mon, 11/14/22 - 07:10 pm
Tags:
Europe, AstraZeneca, Sanofi, COVID-19, cancer, GSK, Regeneron
GSK Restricts the Use of PARP Inhibitor in Ovarian Cancer at the FDA's Request
BioSpace
Sun, 11/13/22 - 07:07 pm
Tags:
GSK, ovarian cancer, Zejula, PARP inhibitors, FDA
Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster
Fierce Pharma
Thu, 11/10/22 - 10:22 pm
Tags:
Sanofi, GSK, COVID-19, Europe, vaccines, boosters
GSK plans phase 3 for hepatitis B drug bepirovirsen, despite efficacy drop
Pharmaphorum
Wed, 11/9/22 - 10:49 am
Tags:
GSK, hepatitis B, bepirovirsen, clinical trials
GSK preps filing for novel antibiotic for urinary tract infections
Pharmaphorum
Mon, 11/7/22 - 10:58 am
Tags:
GSK, antibiotics, UTIs, gepotidacin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.